Amgen
Search results
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
- Alzheimer's Disease
Biogen’s commitment to health equity is rooted in efforts...
- Amyotrophic Lateral Sclerosis
Kate was busy planning her wedding when she was diagnosed...
- Lupus
Biogen’s decades of study at the crossroads of neurology and...
- Multiple Sclerosis
Multiple sclerosis (MS) is a complex, heterogeneous, chronic...
- Spinal Muscular Atrophy
As pioneers in neuroscience, Biogen has an innovative...
- Pipeline
Breaking New Ground With Science. With a strong focus on...
- Alzheimer's Disease
Biogen is a multinational company that develops therapies for neurological diseases. It was founded in 1978 and has acquired several other biotech firms, such as Idec, Conforma, and Syntonix.
Biogen is a leader in developing medicines for neurology, neuropsychiatry, immunology and rare disease. Learn about its history, culture, innovations, clinical trials and health equity initiatives.
Biogen is a biotechnology company that develops medicines for difficult-to-treat diseases. Learn about its pipeline of potential therapies and how to participate in clinical trials.
Biogen is a global biotechnology company that develops innovative medicines for neurological diseases. Follow its LinkedIn page to see its latest news, events, research, and career opportunities.
Biogen is a company that develops and delivers innovative therapies for complex and devastating diseases. Learn about Biogen's pipeline, purpose, culture, and reconciliation journey in Australia.
Jun 7, 2021 · Biogen's stock surged 38% after the FDA cleared its drug aducanumab, which is marketed as Aduhelm, to slow cognitive decline in people with Alzheimer's. The drug targets beta-amyloid, a compound in the brain, but its effectiveness and safety are controversial and uncertain.
